A detailed history of Ubs Asset Management Americas Inc transactions in Pfizer Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 38,068,879 shares of PFE stock, worth $949 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
38,068,879
Previous 31,091,292 22.44%
Holding current value
$949 Million
Previous $870 Million 26.64%
% of portfolio
0.29%
Previous 0.25%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $193 Million - $219 Million
6,977,587 Added 22.44%
38,068,879 $1.1 Billion
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $157 Million - $185 Million
6,233,161 Added 25.07%
31,091,292 $870 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $22.4 Million - $25.7 Million
-865,726 Reduced 3.37%
24,858,131 $690 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $25.3 Million - $32.9 Million
-968,657 Reduced 3.63%
25,723,857 $741 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $58.3 Million - $68.2 Million
1,817,203 Added 7.31%
26,692,514 $885 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $123 Million - $160 Million
-3,117,981 Reduced 11.14%
24,875,311 $1.01 Billion
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $131 Million - $172 Million
3,147,768 Added 12.67%
27,993,292 $1.43 Billion
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $49.6 Million - $60.6 Million
-1,134,047 Reduced 4.37%
24,845,524 $1.09 Billion
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $84.7 Million - $100 Million
1,820,095 Added 7.53%
25,979,571 $1.36 Billion
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $6.4 Million - $7.94 Million
-139,992 Reduced 0.58%
24,159,476 $1.25 Billion
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $23.6 Million - $35 Million
570,667 Added 2.4%
24,299,468 $1.43 Billion
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $18 Million - $23.1 Million
457,513 Added 1.97%
23,728,801 $1.02 Billion
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $51.4 Million - $58.3 Million
1,432,656 Added 6.56%
23,271,288 $911 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $33.7 Million - $38.1 Million
1,007,711 Added 4.84%
21,838,632 $791 Million
Q4 2020

Mar 01, 2021

BUY
$33.47 - $42.56 $9.15 Million - $11.6 Million
273,326 Added 1.33%
20,830,921 $767 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $71.2 Million - $83.5 Million
-2,242,235 Reduced 9.83%
20,557,595 $716 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $10.5 Million - $12.7 Million
-347,586 Reduced 1.5%
22,799,830 $707 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $65.2 Million - $93.2 Million
2,413,129 Added 11.64%
23,147,416 $717 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $5.67 Million - $6.43 Million
172,120 Added 0.84%
20,734,287 $771 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $21.7 Million - $28.1 Million
-668,096 Reduced 3.15%
20,562,167 $701 Million
Q2 2019

Aug 15, 2019

SELL
$36.98 - $41.52 $12.1 Million - $13.6 Million
-327,680 Reduced 1.52%
21,230,263 $0
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $11.4 Million - $12.6 Million
304,692 Added 1.43%
21,557,943 $0
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $9.81 Million - $11.2 Million
255,015 Added 1.21%
21,253,251 $880 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $19.5 Million - $23.6 Million
-564,788 Reduced 2.62%
20,998,236 $0
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $5.83 Million - $6.21 Million
-176,676 Reduced 0.81%
21,563,024 $0
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $58.5 Million - $67.9 Million
1,833,807 Added 9.21%
21,739,700 $0
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $5.19 Million - $5.5 Million
155,942 Added 0.79%
19,905,893 $0
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $612 Million - $674 Million
19,749,951
19,749,951 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.